Valued at a market cap of $241.1 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science, dedicated to its mission of making the world healthier, cleaner, and safer. Through its innovative technologies, industry-leading brands, and comprehensive scientific and pharmaceutical services, the company supports customers in advancing research, improving diagnostics, enhancing laboratory productivity, and developing life-changing therapies.
The Waltham, Massachusetts-based company is slated to announce its fiscal Q3 2026 results before the market opens on Wednesday, Oct. 21. Ahead of the event, analysts expect the company to report an adjusted EPS of $6.40, an increase of 10.5% from $5.79 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarterly reports.